menu search

EVOK / Evoke Pharma to Participate in H.C. Wainwright 24th Annual Global Investment Conference

Evoke Pharma to Participate in H.C. Wainwright 24th Annual Global Investment Conference
SOLANA BEACH, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases, today announced that the Company's President and CEO, David A. Gonyer, R.Ph., and Chief Business Officer, Matt D'Onofrio, MBA, will present at the H.C. Wainwright 24th Annual Global Investment Conference taking place from September 12-14, 2022, at the Lotte New York Palace Hotel in NYC. Read More
Posted: Sep 6 2022, 08:30
Author Name: GlobeNewsWire
Views: 110117

EVOK News  

Evoke Pharma, Inc. (EVOK) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 21, 2023

Evoke Pharma, Inc. (EVOK) Q4 2022 Earnings Call Transcript

Evoke Pharma, Inc. (NASDAQ:EVOK ) Q4 2022 Earnings Conference Call March 21, 2023 4:30 PM ET Company Participants Daniel Kontoh-Boateng - Investor Rel more_horizontal

Evoke Pharma, Inc. (EVOK) Q3 2022 Results - Earnings Call Transcript

By Seeking Alpha
November 9, 2022

Evoke Pharma, Inc. (EVOK) Q3 2022 Results - Earnings Call Transcript

Evoke Pharma, Inc. (NASDAQ:EVOK ) Q3 2022 Results Earnings Conference Call November 10, 2022 4:30 PM ET Company Participants Daniel Kontoh-Boateng - I more_horizontal

Evoke Pharma to Participate in H.C. Wainwright 24th Annual Global Investment Conference

By GlobeNewsWire
September 6, 2022

Evoke Pharma to Participate in H.C. Wainwright 24th Annual Global Investment Conference

SOLANA BEACH, Calif., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on tr more_horizontal

Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q2 2022 Results - Earnings Call Transcript

By Seeking Alpha
August 10, 2022

Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q2 2022 Results - Earnings Call Transcript

Evoke Pharma, Inc. (NASDAQ:EVOK ) Q2 2022 Earnings Conference Call August 10, 2022 4:30 PM ET Company Participants David Gonyer – Chief Executive Of more_horizontal

Evoke Pharma (EVOK) Stock: 1-For-12 Reverse Split Goes Into Effect

By Pulse2
May 23, 2022

Evoke Pharma (EVOK) Stock: 1-For-12 Reverse Split Goes Into Effect

A 1-for-12 reverse stock split of Evoke Pharma (NASDAQ: EVOK) has gone into effect. These are the details. more_horizontal

Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q1 2022 Results - Earnings Call Transcript

By Seeking Alpha
May 10, 2022

Evoke Pharma, Inc. (EVOK) CEO David Gonyer on Q1 2022 Results - Earnings Call Transcript

Evoke Pharma, Inc. EVOK Q1 2022 Earnings Conference Call May 10, 2022 4:30 PM ET Company Participants David Gonyer – Chief Executive Officer Chris Q more_horizontal

Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call Transcript

By Seeking Alpha
March 8, 2022

Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call Transcript

Evoke Pharma, Inc. (EVOK) CEO Dave Gonyer on Q4 2021 Results - Earnings Call Transcript more_horizontal


Search within

Pages Search Results: